Tower Research Capital (TRC)’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57K | Buy |
2,791
+2,009
| +257% | +$41K | ﹤0.01% | 2854 |
|
|
2025
Q1 | $15.7K | Sell |
782
-10,483
| -93% | -$210K | ﹤0.01% | 3209 |
|
|
2024
Q4 | $300K | Buy |
11,265
+7,524
| +201% | +$201K | 0.01% | 1411 |
|
|
2024
Q3 | $107K | Sell |
3,741
-205
| -5% | -$5.85K | ﹤0.01% | 2178 |
|
|
2024
Q2 | $85.9K | Buy |
3,946
+3,756
| +1,977% | +$81.8K | ﹤0.01% | 2684 |
|
|
2024
Q1 | $4.21K | Sell |
190
-5,153
| -96% | -$114K | ﹤0.01% | 4714 |
|
|
2023
Q4 | $115K | Buy |
5,343
+4,366
| +447% | +$94.2K | ﹤0.01% | 2541 |
|
|
2023
Q3 | $16.5K | Sell |
977
-10
| -1% | -$169 | ﹤0.01% | 3555 |
|
|
2023
Q2 | $13.5K | Buy |
987
+362
| +58% | +$4.97K | ﹤0.01% | 3735 |
|
|
2023
Q1 | $14K | Buy |
625
+160
| +34% | +$3.58K | ﹤0.01% | 3873 |
|
|
2022
Q4 | $11K | Sell |
465
-1,356
| -74% | -$32.1K | ﹤0.01% | 3800 |
|
|
2022
Q3 | $47K | Buy |
1,821
+691
| +61% | +$17.8K | ﹤0.01% | 3210 |
|
|
2022
Q2 | $25K | Sell |
1,130
-1,713
| -60% | -$37.9K | ﹤0.01% | 3549 |
|
|
2022
Q1 | $128K | Buy |
2,843
+2,400
| +542% | +$108K | ﹤0.01% | 2029 |
|
|
2021
Q4 | $19K | Sell |
443
-2,236
| -83% | -$95.9K | ﹤0.01% | 3709 |
|
|
2021
Q3 | $178K | Sell |
2,679
-1,769
| -40% | -$118K | ﹤0.01% | 1921 |
|
|
2021
Q2 | $326K | Buy |
4,448
+606
| +16% | +$44.4K | 0.01% | 1528 |
|
|
2021
Q1 | $263K | Sell |
3,842
-5,016
| -57% | -$343K | ﹤0.01% | 1774 |
|
|
2020
Q4 | $595K | Buy |
8,858
+455
| +5% | +$30.6K | 0.02% | 867 |
|
|
2020
Q3 | $432K | Buy |
8,403
+6,295
| +299% | +$324K | ﹤0.01% | 1844 |
|
|
2020
Q2 | $79K | Buy |
+2,108
| New | +$79K | ﹤0.01% | 2654 |
|
|
2020
Q1 | – | Sell |
-2,476
| Closed | -$85K | – | 3168 |
|
|
2019
Q4 | $85K | Buy |
+2,476
| New | +$85K | 0.01% | 1033 |
|